Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia

Tait Shanafelt, Clive Zent, John Byrd, Charles Erlichman, Betsy Laplant, Asish Ghosh, Timothy Call, Miguel Villalona-Calero, Diane Jelinek, Deborah Bowen, Kristina Laumann, Wenting Wu, Curtis Hanson, Neil Kay

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences